NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Real Goods Solar, Inc. (NASDAQ:RGSE), LivePerson, Inc. (NASDAQ:LPSN), Manhattan Associates, Inc. (NASDAQ:MANH), Natus Medical Incorporated (NASDAQ:BABY), BioScrip, Inc. (NASDAQ:BIOS), and FBL Financial Group, Inc. (NYSE:FFG), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
RGSE DOWNLOAD: http://Fundamental-Markets.com/register/?so=RGSE
LPSN DOWNLOAD: http://Fundamental-Markets.com/register/?so=LPSN
MANH DOWNLOAD: http://Fundamental-Markets.com/register/?so=MANH
BABY DOWNLOAD: http://Fundamental-Markets.com/register/?so=BABY
BIOS DOWNLOAD: http://Fundamental-Markets.com/register/?so=BIOS
FFG DOWNLOAD: http://Fundamental-Markets.com/register/?so=FFG
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Real Goods Solar, Inc. (NASDAQ:RGSE), LivePerson, Inc. (NASDAQ:LPSN), Manhattan Associates, Inc. (NASDAQ:MANH), Natus Medical Incorporated (NASDAQ:BABY), BioScrip, Inc. (NASDAQ:BIOS), and FBL Financial Group, Inc. (NYSE:FFG) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 19th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
REAL GOODS SOLAR, INC. (RGSE) REPORT OVERVIEW
Real Goods Solar's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Real Goods Solar reported revenue of $4.02MM vs $2.48MM (up 62.19%) and basic earnings per share -$0.59 vs -$308.10. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Real Goods Solar reported revenue of $17.43MM vs $45.53MM (down 61.73%) and basic earnings per share -$183.54 vs -$770.00.
To read the full Real Goods Solar, Inc. (RGSE) report, download it here: http://Fundamental-Markets.com/register/?so=RGSE
-----------------------------------------
LIVEPERSON, INC. (LPSN) REPORT OVERVIEW
LivePerson's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, LivePerson reported revenue of $57.39MM vs $56.12MM (up 2.27%) and basic earnings per share -$0.07 vs -$0.17. For the twelve months ended December 31st, 2017 vs December 31st, 2016, LivePerson reported revenue of $218.88MM vs $222.78MM (down 1.75%) and basic earnings per share -$0.32 vs -$0.46. LivePerson is expected to report earnings on May 9th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.02. The estimated EPS forecast for the next fiscal year is $0.00 and is expected to report on February 19th, 2019.
To read the full LivePerson, Inc. (LPSN) report, download it here: http://Fundamental-Markets.com/register/?so=LPSN
-----------------------------------------
MANHATTAN ASSOCIATES, INC. (MANH) REPORT OVERVIEW
Manhattan Associates' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Manhattan Associates reported revenue of $144.09MM vs $147.59MM (down 2.38%) and basic earnings per share $0.36 vs $0.42 (down 14.29%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Manhattan Associates reported revenue of $594.60MM vs $604.56MM (down 1.65%) and basic earnings per share $1.68 vs $1.73 (down 2.89%). Manhattan Associates is expected to report earnings on April 19th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.40. The estimated EPS forecast for the next fiscal year is $1.11 and is expected to report on February 5th, 2019.
To read the full Manhattan Associates, Inc. (MANH) report, download it here: http://Fundamental-Markets.com/register/?so=MANH
-----------------------------------------
NATUS MEDICAL INCORPORATED (BABY) REPORT OVERVIEW
Natus Medical's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Natus Medical reported revenue of $131.44MM vs $107.70MM (up 22.04%) and basic earnings per share -$0.22 vs $0.32. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Natus Medical reported revenue of $500.97MM vs $381.89MM (up 31.18%) and basic earnings per share -$0.62 vs $1.31. Natus Medical is expected to report earnings on April 25th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.30. The estimated EPS forecast for the next fiscal year is $1.92 and is expected to report on February 6th, 2019.
To read the full Natus Medical Incorporated (BABY) report, download it here: http://Fundamental-Markets.com/register/?so=BABY
-----------------------------------------
BIOSCRIP, INC. (BIOS) REPORT OVERVIEW
BioScrip's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, BioScrip reported revenue of $198.69MM vs $224.54MM (down 11.51%) and basic earnings per share -$0.12 vs -$0.12. For the twelve months ended December 31st, 2016 vs December 31st, 2015, BioScrip reported revenue of $935.59MM vs $982.22MM (down 4.75%) and basic earnings per share -$0.54 vs -$4.51. BioScrip is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.16. The estimated EPS forecast for the next fiscal year is -$0.16 and is expected to report on March 14th, 2019.
To read the full BioScrip, Inc. (BIOS) report, download it here: http://Fundamental-Markets.com/register/?so=BIOS
-----------------------------------------
FBL FINANCIAL GROUP, INC. (FFG) REPORT OVERVIEW
FBL Financial Group's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, FBL Financial Group reported revenue of $183.01MM vs $184.18MM (down 0.64%) and basic earnings per share $4.34 vs $1.08 (up 301.85%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, FBL Financial Group reported revenue of $735.48MM vs $726.41MM (up 1.25%) and basic earnings per share $7.76 vs $4.29 (up 80.89%). FBL Financial Group is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $1.08. The estimated EPS forecast for the next fiscal year is $5.18 and is expected to report on February 14th, 2019.
To read the full FBL Financial Group, Inc. (FFG) report, download it here: http://Fundamental-Markets.com/register/?so=FFG
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade--and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.